Windtree Therapeutics to Invest $700 Million in BNB, Following Corporate Crypto Trend

preview image

Nasdaq-listed biopharmaceutical company Windtree Therapeutics has announced its intention to acquire up to $700 million worth of BNB, the native cryptocurrency of the BNB Chain. This significant investment follows a recent all-time high for BNB and aligns with a growing trend of publicly traded companies diversifying their treasuries with digital assets.

Read more

Comments

Popular posts from this blog

BitMEX Exposes Lazarus Group's Cyber Security Vulnerabilities